- nib holdings, Pilbara, and Medibank have witnessed significant growth in their share price in the past year.
- nib holdings announced the retirement of Mr Steve Crane, Non-Executive Director and Chairman.
- Pilbara’s Board approved the staged resume of the Ngungaju Plant.
- Medibank would give back ~AU$105 million in COVID-19 permanent net claims savings to clients via premium relief.
Medibank, nib holdings, and Pilbara, are among the shares under discussion, primarily due to the impressive growth demonstrated in the past year.
nib holdings announced the retirement of Mr Steve Crane, its Non-Executive Director and Chairman. Besides, the Company appointed Mr Peter Harmer as an Independent Non-Executive Director of the nib Board.
Pilbara’s Board approved the staged resume of the Ngungaju Plant, while Medibank announced that it would return ~AU$105 million in COVID-19 permanent net claims savings to the clients via premium relief.
This article will walk you through these latest developments.
nib holdings limited (ASX:NHF)
On 20 July 2021, private health insurance company nib holdings limited hit a 52-week high price. In the last year, the shares have improved by 44.16%.
Yesterday, the Company declared that Mr Steve Crane, NHF’s Non-Executive Director & Chairman, would resign from the Board on 29 July 2021. His position would be taken up by Mr David Gordon, who is the existing Independent Non-Executive Director.
NHF also declared the appointment of Mr Peter Harmer as an Independent Non-Executive Director of the Board. Mr Harmer has more than 40 years of knowledge in the Australian and international insurance as well as financial sectors.
Copyright © 2021 Kalkine Media
Mr Harmer started serving the Board as an additional director from 20 July 2021 and would stand for election at 2021 AGM in November 2021.
On 20 July, NHF shares settled at AU$6.790, up 3.191% from their previous close.
Pilbara Minerals Limited (ASX:PLS)
Lithium and tantalum producer and explorer Pilbara Minerals Limited has witnessed its shares hit the roof in the last 12 months with a massive 329% jump. The share price has moved significantly in 2021 as well, moving up by ~69%.
On 25 June 2021, Pilbara announced that it took major moves to increase spodumene concentrate production at its wholly owned Pilgangoora Project situated in WA. Following the Board’s consent of the staged resume of the Ngungaju Plant, it is anticipated these operations will resume during the Q4 CY2021, targeting an annual total production capacity of 180K to 200K dry metric tonnes by mid of CY2022. This will see the collective annual production capacity of the Pilgangoora Project surge from 560K to 580K dry metric tonnes.
On 20 July, PLS shares closed at AU$1.455.
- Pilbara Minerals (ASX:PLS) reports significant assay results at Pilgangoora Project, shares up 3.5%
- Pilbara Minerals (ASX:PLS) encounters ‘exceptional’ drilling results at Pilgangoora
Medibank Private Limited (ASX:MPL)
Private health insurance company Medibank Private Limited shares recently reached their 52-week high. On 20 July 2021, the shares settled at AU$3.300, up 0.917% from their previous close.
On 20 June 2021, the Company announced that it would return ~AU$105 million in COVID-19 permanent net claims savings to clients via premium relief in the next stage of its broader ‘COVID-19 financial support package and give back program’.
The give back adds to MPL’s record AU$195 million financial support package during COVID-19, and the total package reached AU$300 million. The package would be offered to Australian Medibank and ahm clients having an active hospital or extras policy or both between 1 July 2020 and 30 June 2021.
Around 2 million policies would be qualified, and most customers should anticipate getting the premium relief by the closure in September 2021.